Biophan allies with Boston Scientific

Article

Biophan Technologies has entered into a joint development agreement with Boston Scientific to create a variety of devices that are safe and compatible with MRI. The two companies will also explore possible licensing agreements under the alliance. The

Biophan Technologies has entered into a joint development agreement with Boston Scientific to create a variety of devices that are safe and compatible with MRI. The two companies will also explore possible licensing agreements under the alliance. The joint development agreement will support R&D aimed at resolving problems caused by the interference that results from metal objects in the field-of-view of MR scanners. This interference can obscure tissue and raise safety concerns. Biophan has developed a coating technology that reduces image interference caused by metal objects. It is also developing implantable devices, such as cardiac pacemakers, that are MR-compatible.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.